|
Aug 26
|
J&J (JNJ) Gets EU Approval for Bladder Cancer Drug Balversa
|
|
Jun 15
|
Insider Sale: CFO Andy Sassine Sells 50,000 Shares of Arcturus Therapeutics Holdings Inc (ARCT)
|
|
Jun 7
|
Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference
|
|
May 28
|
Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program
|
|
May 22
|
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
|
|
May 20
|
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics’ COVID-19 Vaccine
|
|
May 15
|
Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences
|
|
May 9
|
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Arcturus Therapeutics Holdings First Quarter 2024 Earnings: Beats Expectations
|
|
May 9
|
Arcturus Therapeutics Holdings Inc (ARCT) (Q1 2024) Earnings Call Transcript Highlights: ...
|
|
May 8
|
Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress
|
|
May 2
|
Gritstone bio Inc. (GRTS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
May 1
|
Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 29
|
Arcturus Therapeutics Holdings' (NASDAQ:ARCT) investors will be pleased with their impressive 284% return over the last five years
|
|
Apr 25
|
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024
|
|
Mar 28
|
Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares
|
|
Mar 22
|
Arcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO Pad Chivukula Sells ...
|
|
Mar 17
|
Arcturus Therapeutics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
|
Mar 9
|
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
|
|
Mar 8
|
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript
|